Skip to main content
. Author manuscript; available in PMC: 2018 Apr 29.
Published in final edited form as: Sex Health. 2016 Apr;13(2):155–161. doi: 10.1071/SH15124

Table 2.

Clinical end-point univariate- and covariate-adjusted Cox proportional hazard ratios

End-point Hazard ratio
(female
vs male)		 95%
confidence
intervals		 P-value
All-cause mortality
  Univariate 0.89 0.51–1.55 0.67
  MultivariableA 0.98 0.56–1.75 0.97
AIDS illness
  Univariate 0.76 0.39–1.48 0.42
  MultivariableA 0.75 0.38–1.48 0.41
All-cause mortality & AIDS illness (combined)
  Univariate 0.70 0.43–1.14 0.16
  MultivariableA 0.74 0.45–1.21 0.23
A

Adjusted for age at cohort enrolment, injecting drug use (IDU) HIV exposure, hepatitis C virus (HCV), hepatitis B virus (HBV), recent CD4 cell count, recent HIV viral load ≥100 000 copies mL−1, year of cohort enrolment, number antiretroviral therapy (ART) modifications and clinical care setting.